clinical trial · NCT04883905
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
Acute Hepatic Porphyria
brief summary
This global patient registry is being conducted to characterize the natural history and real-world clinical management of patients with AHP, and to further characterize the real-world safety and effectiveness of givosiran and other approved AHP therapies.
started
Apr 26, 2021
primary completion
Dec 31, 2030
completion
Dec 31, 2030
last updated
Sep 8, 2026
official title
ELEVATE, a Global Observational Longitudinal Prospective Registry of Patients With Acute Hepatic Porphyria (AHP)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol